Doru M. Paul, M.D., Ph.D.
Locations and Appointments
Center for Community Health at NewYork-Presbyterian Brooklyn Methodist Hospital
Head and Neck Cancer Program
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
- 1199 National Benefit Fund
- AETNA
- Aetna - NYP
- Aetna [Weill Cornell Employee Plan]
- Affinity Health Plan
- Amida Care
- CIGNA
- Emblem/Hip
- Empire Blue Cross/Blue Shield
- Empire Blue Cross/Blue Shield Healthplus
- GHI
- Health Insurance Plan of NY (HIP)
- Multiplan
- Oxford Health Plans
- Rockefeller University - CoreSource
- Unicare
- United Healthcare
- UnitedHealthcare
- VNSNY CHOICE
- WellCare
About Doru M. Paul, M.D., Ph.D.
Dr. Paul is an expert in the treatment of head and neck and lung cancer with a track record of developing successful multidisciplinary approaches to treatof these conditions. He has also made major contributions as a translational and clinical researcher. Demonstrating a national and international presence in his field, he has widely presented his research defining specific therapeutic targets or processes that can be targeted for the improved treatment of cancer patients.Dr. Paul received his MD from the Carol Davila Faculty of Medicine in Bucharest, Romania in 1993. At the Faculty of Paris 7, in 1995 he received his Clinical Oncology Diploma and in 1996 he received his Chronobiology Diploma and a Masters Degree in the Biology of Aging from the Faculty of Paris 6. In 2016, Dr. Paul received a PhD summa cum laude in Personalized Clinical Oncology, from the Faculty of Medicine in Craiova, Romania. Following his internal medicine residency at the Jacobi Hospital in the Bronx, he completed a hematology and medical oncology fellowship at Montefiore Hospital in 2002. He was a junior faculty member at Weill Cornell Medical College from 2003-2012 when he served as an Attending Physician in Hematology-Oncology at Lincoln Medical and Mental Health Center. Since 2012, he has been an Assistant Professor of Medicine at the Northwell Hofstra School of Medicine and an Attending Physician at the Northwell Health Monter Cancer Center. He has also been an Assistant Professor at the Feinstein Institute for Medical Research since 2017.Dr. Paul has a strong background as a translational and clinical researcher. Since 2003, he has been Principal Investigator or Local Principal Investigator on 27 studies, and co-Principal Investigator on 5 others. He has designed and conducted several investigator-initiated studies and initiated 2 FDA approved investigational new drug studies. The results of Dr. Paul's research have been significant. He designed the first in-man pilot study that uses [18F] Fluorodeoxyglucose (FDG) for the targeted treatment of cancer, obtaining approval from the FDA and funding from the Northwell Health Cancer Institute.
Board Certifications
- Hematology
- Internal Medicine
- Medical Oncology
Expertise
Cancer
Cancer Genetics
Cancer Immunotherapy
Cancer Pain Management
Cancer Treatment
Chemotherapy
Chemotherapy Infusion
Head & Neck Tumors
Head and Neck Cancers
Image Guided Radiation Therapy
Immunotherapy
Lung Cancer
Lung Cancer-Diagnostic Testing
Metastatic Cancer
Oncology
Thyroid Cancer
Education
Fellowship: Montefiore Hospital
Residency: Jacobi Medical Center
Languages
- English
Titles & Positions
Associate Attending Physician
Associate Professor of Clinical Medicine
Hospital Affiliations
NewYork-Presbyterian / Weill Cornell Medical Center
Education
- Residency: Jacobi Medical Center
- Fellowship: Montefiore Hospital
Titles & Positions
- Associate Attending Physician
- Associate Professor of Clinical Medicine
Board Certifications
- Hematology
- Internal Medicine
- Medical Oncology
Languages Spoken
- English